Switzer TV

Peter Switzer is joined by three expert guests to unpack the biggest stories shaping markets, property and innovation this week.

– Paul Rickard (Switzer Report) breaks down how the Trump vs China rare earths dispute has shaken Wall Street, what it means for Australian investors, and how the government’s Super Tax changes will impact super funds and high-balance investors. He also names the ASX stocks he believes represent strong value opportunities right now.

– Simon Pressley, Head of Research at Propertyology, challenges the mainstream housing headlines, revealing the biggest myths about the Australian property market, why “location, location, location” is often misunderstood, and how SMSFs can still be used strategically for property investing.

– Dr David Burton (CEO) and David Lawson (CFO) from Compumedics (ASX: CMP) discuss their company’s latest results, global expansion plans in sleep diagnostics and brain monitoring, and whether tech giants like Google or Apple pose a threat to their future growth.

📈 Stay informed with Switzer Investing TV — where Peter Switzer and Australia’s top thinkers help you make smarter decisions in markets, business and life.

👉 Subscribe for weekly analysis, interviews and insights from the country’s most trusted financial voices.

#Investing #Markets #Superannuation #Property #SwitzerInvestingTV #ASX #Compumedics #PeterSwitzer #PaulRickard #SimonPressley

Switzer Investing TV | 13 Oct 2025: Super Tax changes incoming | Trump v China, Part II | Busting Australian property myths

Peter Switzer is joined by three expert guests to unpack the biggest stories shaping markets, property and innovation this week.

More videos

TOP STOCKS from reporting season! + Why these areas for property are looking attractive!

Peter Switzer is joined by ST Wong of Prime Value, CFO of BHP, David Lamont, and Margaret Lomas of Destiny Financial Solutions.

Series:
Mad about Money

Peter Switzer and Paul Rickard share their thoughts on the major current affairs impacting financial markets and the economy.

Series:
The star stocks from reporting season: Telstra, BlueScope, Lovisa + 10 tech stocks analysts love!

Peter Switzer is joined by Michael Wayne of Medallion Financial Group, Adam Dawes of Shaw and Partners, and Paul Rickard from the Switzer Report.

Series:
What is the immune system and what exactly does it do? | The Check Up

In this week's episode, Dr Ross tells us what exactly the immune system is and how it works.

Series:
Is it buy time for stocks with US inflation better than expected? + Stocks in focus: BHP, REA, XRO!

Peter Switzer is joined by Marcus Bogdan of Blackmore Capital, Paul Rickard from the Switzer Report, and senior economist at REA Group, Eleanor Creagh.

Series:
Mad about Money

Peter Switzer and Paul Rickard share their thoughts on the major current affairs impacting financial markets and the economy.

Series:
Is the stock market poised to boom or slump? + We rate these stocks: REA, AD8, BHP & more!

Peter Switzer is joined by Jun Bei Liu of Tribeca Alpha Plus, Michael Gable of Fairmont Equities, and Paul Rickard from the Switzer Report.

Series:
Why it's important to have a healthy immune system | The Check Up

Dr Ross discusses the importance on having a healthy immune system, especially if you contract COVID-19.

Series:
Is it time to have the guts to buy stocks? + Can't buy where you want to live? Try rentvesting!

Peter Switzer is joined by Anna Porter of Suburbanite, Paul Rickard discusses what's ahead for the August reporting season and is joined by Lloyd Edge of Aus Property Professionals.

Series:
Mad about Money

Peter Switzer and Paul Rickard share their thoughts on the major current affairs impacting financial markets and the economy.

Series:
Is EML worth gambling on with a new CEO? Zip and Megaport on a rebound? + ELMO's FY22 results!

Paul Rickard is joined by Adam Dawes of Shaw and Partners, Raymond Chan of Morgans, and Peter Switzer speaks with CFO of ELMO Software, James Haslam.

Series:
Why taking Vitamin D is so beneficial for our bodies | The Check Up

Dr Ross discusses how beneficial taking two capsules of Vitamin D a day is, with studies showing a 22% reduction in common autoimmune diseases.

Series:
1 11 12 13 14 15 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram